Tech

The research behind medical cannabis in Argentina

More and more consumers are using cannabis products and derivatives. However, access to safe cannabis oil remains restricted and complex. Marplatenses of CONICET and the National University of Mar del Plata in Argentina develop techniques to characterize cannabis oil, addressing the issue with other social actors, reporting important aspects of the use of cannabis medicine.

Currently, in Argentina, medical cannabis oil can be prescribed only for the treatment of diseases like epilepsy and the product is imported. Groups are working to provide a service that reports on its composition and quality.

This is essential because its health effects are directly related to the proportion of compounds in the different varieties of the cannabis plant. Often, patients who consume it for other medical conditions obtain cannabis oil illegally. 

Knowing the composition

A team of scientists in Mar del Plata is working to provide analysis services so that patients know the composition of the oil they are consuming. Although this service is already available in some parts of the country, in Mar del Plata it is not yet available.

They began to work with cannabis for medical purposes at the end of 2016. The goal is to look for alternatives to treatments for chronic pain. They work with the Marplatense Association of Cannabicultores and many families that were using cannabis to treat symptoms.

To advance in the investigations, the National Program for the scientific investigation on cannabis must still be formalized. This indicates the steps followed in order to access the plant material and carry out the research work. Waiting for this program is an impediment for the projects to continue working.

The public production of oil begins in order to avoid the existence of the black market. (Source)

Developing a method

The group of researchers is part of the Argentine Medical cannabis Network (RACME). They are composed of professionals from different disciplines nationwide. In addition, they are working on an agreement that allows the development of a method to identify and quantify cannabinoids. They use different varieties of cannabis sativa and generate secondary patterns with the Environmental Research Center of the National University of La Plata and CONICET.

Many of these issues will be discussed in “Dialogues on Medicinal cannabis,” whose panel will be made up of Silvana Colman, Ariel Cherro, a certified clinical doctor in palliative care belonging to the Argentine Society of Medicine, Alejandra Fanovich, an independent researcher at CONICET, Juan Tapia, Judge of Guarantees and holder of the Court of Guarantees Nº 4 of the Judicial Department of Mar del Plata and Susana La Rocca, Coordinator of the Interdisciplinary Thematic Program in Bioethics of the National University of Mar del Plata. The activity will take place at 2 pm and with free and free admission and with limited spaces in the room, in the Cinemas Level of Los Gallegos Shopping, Rivadavia 3050. For more information: comunicacion@mardelplata-conicet.gob.ar

(Featured Image by Kitt_KS)

First published in La Capital, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although the author made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the content provided on this website. Any person or entity relying on the translations does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Michael Jermaine Cards

Michael Jermaine Cards is a business executive and a financial journalist, with a focus on IT, innovation and transportation, as well as crypto and AI. He writes about robotics, automation, deep learning, multimodal transit, among others. He updates his readers on the latest market developments, tech and CBD stocks, and even the commodities industry. He does management consulting parallel to his writing, and has been based in Singapore for the past 15 years.

Recent Posts

Berlin Will Launch Pilot Project for Legal Cannabis Sales

Berlin is launching a pilot project in the Friedrichshain-Kreuzberg and Neukölln districts to study the…

1 week ago

Legalizace, Czech Cannabis Magazine, Accused of “Promoting Drug Addiction”, Wins Case

The Czech Constitutional Court overturned a previous ruling accusing Robert Veverka, former editor of Legalizace,…

2 weeks ago

U.N. High Commissioner for Human Rights Declares the War on Drugs a Failure

U.N. High Commissioner for Human Rights Volker Türk has declared the war on drugs a…

2 weeks ago

Pennsylvania Lawmakers Unveil New Plan to Legalize Cannabis

Pennsylvania lawmakers have proposed a plan to legalize recreational cannabis by 2025. Projections estimate up…

2 weeks ago

United States — First Step in DEA Hearing on Cannabis Reclassification

The DEA just held its first procedural hearing on cannabis reclassification, although the focus was…

3 weeks ago

Brazil — Supreme Court Legalizes the Cultivation, Processing, and Sale of Hemp for Medical Purposes

The Superior Court of Justice in Brazil has legalized the cultivation, processing, and sale of…

3 weeks ago